We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Evaluate Safety and Effectiveness of MBX-102 in Type 2 Diabetes Patients With Poor Glycemic Control on Metformin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00814372
Recruitment Status : Terminated (MBX-102 did not meet the target efficacy profile of HbA1c change.)
First Posted : December 24, 2008
Last Update Posted : April 17, 2015
Information provided by (Responsible Party):
CymaBay Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : February 2010
  Study Completion Date : February 2010
  Certification or Request for Extension to Delay Results Submission: February 16, 2015